Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,46116,480 of 20,252 grants

Active NON-SBIR/STTR RPGS
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

ABSTRACT Acute myeloid leukemias (AMLs) are a genetically heterogeneous group of clonal hematopoietic disorders characterized by accumulation of immature non-lymphoid marrow progen...

$3.56M
USD
Active NON-SBIR/STTR RPGS
Low Cost Tethered Capsule Endoscope with High-Resolution Digital Chromoscopy for Barrett's Screening
NATIONAL CANCER INSTITUTE Rice University United States 2021 – 2026

Abstract Esophageal cancer is the 6th leading cause of cancer death worldwide; rates of esophageal adenocarcinoma (EAC) haverisen exponentially over the past 4 decades. When EAC is...

$6.28M
USD
Completed OTHER RESEARCH-RELATED
Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a lethal blood cancer characterized by a clonal expansion of precursor blood- forming cells. Intensive chemotherapy has bee...

$2.55M
USD
Completed NON-SBIR/STTR RPGS
A Novel Paradigm for the Development of a Peptide Vaccine to Treat KRAS Mutant Cancers
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2023

Abstract Ras mutations are highly prevalent in many human tumors but translating this major discovery into effective therapeutics has been difficult. Immunotherapy has emerged as t...

$1.81M
USD
Completed NON-SBIR/STTR RPGS
Role and Mechanisms of VAV1 alterations in Peripheral T-cell Lymphomas
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2026

Project Summary/Abstract Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous and poorly understood pathological group of non-Hodgkin lymphomas associated with poor progno...

$3.63M
USD
Active NON-SBIR/STTR RPGS
Personalized Adoptive T-cell Therapy for AML
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

Abstract/Project Summary The development of strategies to expand and activate AML specific T cells is of critical importance. We have developed a personalized cancer vaccine in whi...

$7.17M
USD
Active OTHER RESEARCH-RELATED
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY Immune checkpoint inhibitors (ICIs) provide durable clinical responses in about 20% of cancer patients, but have minimal effects in cancers lacking intra–tumoral T...

$2.22M
USD
Completed SBIR-STTR RPGS
Ultra-sensitive Singlet Oxygen Dosimeter for Skin Cancer Treatment and Prevention
NATIONAL CANCER INSTITUTE Physical Sciences, Inc United States 2021 – 2025

Project Summary/Abstract Skin cancer is the most common form of cancer. Each year in the U.S. alone over 5.4 million cases of nonmelanoma skin cancer are treated. The annual cost o...

$9.06M
USD
Active NON-SBIR/STTR RPGS
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Cancer cells are embedded in a protective and nourishing “niche”, an environment that cancer cells create by secreting proteins into their surroundings. Because cancer cells depend...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Cellular Sources of Pathological Stromal Variants
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2024

Hepatocellular carcinoma (HCC) accounts for >80% of primary liver cancers and is the fourth most common cause of cancer-related death. Based on populations projections in 2005,...

$2.04M
USD
Active NON-SBIR/STTR RPGS
Statistical methods for cancer mutational signatures
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary Carcinogens and evolutionary pressures generate unique patterns in the types of somatic mutations observed in the DNA of cancer cells. Mutational signature analysis...

$3.91M
USD
Completed NON-SBIR/STTR RPGS
Engineered Enteric Nervous System-Peri Neural Invasion platform to improve predictive preclinical screens in early-stage colorectal adenocarcinomas
NATIONAL CANCER INSTITUTE Texas Engineering Experiment Station United States 2021 – 2024

PROJECT SUMMARY The objective of this proposal is to engineer and utilize enteric nerve plexi as a tool to improve predictive accuracy of preclinical screens in early stage II-III...

$1.69M
USD
Completed NON-SBIR/STTR RPGS
Precision targeting of bladder cancer using CRISPR technology
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2023

ABSTRACT Chromosome rearrangements are common in cancers and typically occur early in carcinogenesis. They drive tumor development by altering the expression or function of oncogen...

$2.14M
USD
Active NON-SBIR/STTR RPGS
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

Prostate cancer is characterized by large genomic rearrangements and deletions. We show that the genes CHD1 and MAP3K7 are co-deleted in ERG translocation negative prostate cancer....

$3.84M
USD
Active NON-SBIR/STTR RPGS
MyGI Diet for Colorectal Cancer Prevention
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2026

PROJECT SUMMARY Despite the large body of research that has identified the impact of diet on cancer risk, little has been done to translate these findings to clinical settings. Her...

$5.79M
USD
Completed NON-SBIR/STTR RPGS
Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models
NATIONAL CANCER INSTITUTE University of Liverpool United Kingdom 2021 – 2023

Project Summary Radiotherapy is still one of the most effective cancer treatments used to treatment ~50 % of all human cancers, and particularly solid tumours of the head and neck...

$3.29M
USD
Completed OTHER RESEARCH-RELATED
A transcription-independent role of HSF1 in tumorigenesis via suppression of AMPK
NATIONAL CANCER INSTITUTE University of Toledo Health Sci Campus United States 2021 – 2024

Project Summary There is an urgent need to develop new therapeutic options for carcinogenesis.The goal of this proposal is to help fulfill this need by shedding new light on the mo...

$1.62M
USD
Active NON-SBIR/STTR RPGS
Improving the Timeliness and Quality of Care for Rural Lung and Head-and-Neck Cancer Patients
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2027

ABSTRACT: Improving the timeliness and quality of care for lung cancer (LC) and head and neck cancer (HNC) patients is of utmost importance because delays in treatment initiation a...

$5.62M
USD
Active OTHER RESEARCH-RELATED
Decision Support for Multigene Panel Testing and Family Risk Communication among Racially/Ethnically Diverse Young Breast Cancer Survivors
NATIONAL CANCER INSTITUTE Florida Atlantic University United States 2021 – 2026

Project Summary/Abstract: The introduction of multi-gene panel testing for hereditary breast and ovarian cancer (HBOC) syndrome has rapidly changed the clinical approach to genetic...

$1.55M
USD
Completed NON-SBIR/STTR RPGS
Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models
NATIONAL CANCER INSTITUTE University of Liverpool United Kingdom 2021 – 2026

Project Summary Radiotherapy is still one of the most effective cancer treatments used to treatment ~50 % of all human cancers, and particularly solid tumours of the head and neck...

$4.31M
USD